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http://dx
1172Objectives: A previously published randomized clinical trial comparing cardiac magnetic resonance (CMR)
versus routine catheterization in patients with functional single ventricle before bidirectional Glenn (BDG) op-
eration demonstrated similar short-term post-BDG outcomes. We sought to assess late outcomes in this cohort to
ascertain any long-term effects of this evaluation strategy.
Methods: Retrospective review of enrolled patients through most recent follow-up was performed on all 82 pa-
tients in the original cohort, at a median age of 8.8 years.
Results: Of these, 76 (93%) underwent Fontan operation; 2 died before Fontan. Baseline demographics, ana-
tomic factors, and age at BDG did not differ between those randomized to CMR versus catheterization. Although
pre-BDG CMR patients were younger at Fontan (2.4 vs 2.7 years; P¼ .02), baseline weight, body surface area,
oxygen saturation, ventricular function, and degree of atrioventricular valve regurgitation were similar. Cathe-
terization before Fontan (n¼ 76) demonstrated similar hemodynamic parameters including pulmonary vascular
resistance and mean pulmonary artery, atrial, and ventricular end-diastolic pressures. CMR patients had compa-
rable rates of transcatheter interventions (71% vs 79%;P¼ .6), including coil occlusion of systemic–pulmonary
collaterals (66% vs 61%; P¼ .29). At Fontan surgery, short-term complications, hospital length of stay, and the
percent meeting a 5-part definition of successful Fontan operation were not different (71% vs 55%; P ¼ .23).
Conclusions: Pre-BDG CMR and catheterization groups had equivalent clinical and hemodynamic profiles be-
fore Fontan and similar post-Fontan outcomes at a median follow-up of 8 years after BDG. For selected patients,
a pre-BDG evaluation with CMR is an acceptable alternative to catheterization. (J Thorac Cardiovasc Surg
2013;146:1172-8)Earn CME credits at
http://cme.ctsnetjournals.org
Patients with congenital heart disease characterized by
a functional single ventricle typically undergo a series of
palliative operations that result in passive systemic venous
flow through the pulmonary circulation and a functional sin-
gle ventricle supporting the systemic circulation. Anasto-
mosis of the superior vena cava to the pulmonary artery,
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The Journal of Thoracic and Cardiovascular Surprocedure typically performed in infancy as an intermediate
step before completion of a Fontan operation. For many
years, routine pre-BDG cardiac catheterization in these pa-
tients has been considered the standard of care, providing
the assessment of anatomic and hemodynamic suitability
for surgery, as well as potential for catheter-based interven-
tions. However, catheterization in this high-risk group of in-
fants is associated with significant morbidity,1,2 and
exposure to ionizing radiation in childhood has been
linked to increased risk of subsequent cancer.3 Retrospec-
tive studies have demonstrated that patients are rarely ex-
cluded from BDG operation on the basis of findings at
cardiac catheterization,1,4 and the benefit of some
transcatheter interventions performed in this setting has
been questioned.5-7
More recently, cardiac magnetic resonance (CMR) imag-
ing has emerged as a useful diagnostic tool in the assessment
of patients with a wide range of congenital heart disease, in-
cluding those with functional single ventricle, allowing for
the accurate evaluation of thoracic vascular anatomy,8 blood
flow,9 ventricular volume and function,10 and myocardial
viability. Unlike echocardiography, which greatly depends
on acoustic windows and indeed has been demonstrated to
correlate poorly with catheter angiography for thegery c November 2013
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is not hindered by acoustic windows or geometric con-
straints and has been proposed as a noninvasive imaging al-
ternative to routine catheterization before BDG.1,8
We2 previously performed a single-center, prospective
randomized clinical trial to test the hypothesis that a nonin-
vasive imaging strategy using CMR could provide the nec-
essary anatomic and functional information required to
safely evaluate such patients (ClinicalTrials.gov number:
NCT00112424). Eighty-two patients presenting for BDG
were randomized to either CMR or catheterization before
BDG and were followed up through the perioperative pe-
riod to 3 months after BDG. Routine cardiac catheterization
was associated with higher rates of minor adverse events
(36 vs 3 patients; P< .001), longer hospital stay (2 vs
days; P< .001), and higher hospital charges than CMR
for the pre-BDG evaluation. In addition, the study also
found no detectable differences in immediate and short-
term postoperative outcomes.
However, the clinical follow-up period for this trial was
only 3 months after BDG, raising issues regarding the po-
tential for longer-term differences in outcomes between
the 2 groups. Of particular interest was the fact that pre-
BDG transcatheter interventions, which were not specified
by trial design but left up to the discretion of the operator,
were performed in 41% of patients in the catheterization
arm of the study as opposed to 2% in the CMR group.
This raises the possibility of a potential benefit for the cath-
eterization group over the longer term from such interven-
tions if there is a delayed therapeutic effect. We thus
sought to determine whether longer-term effects of a nonin-
vasive pre-BDG imaging strategy could be demonstrated
through comprehensive follow-up of the original cohort in-
cluding subsequent interventions, diagnostic imaging stud-
ies, operations, and clinical status at most recent follow-up.METHODS
Patients
A complete description of the enrollment criteria and study design for
the original trial may be found in the original report.2 In brief, eligible pa-
tients were between the ages of 2 months and 5 years referred to Boston
Children’s Hospital for preoperative evaluation before BDG operation
and had no contraindication to CMR (eg, pacemaker). After a protocol-
mandated screening echocardiogram, patients were excluded for prede-
fined indication(s) for cardiac catheterization, including pulmonary vein
stenosis, pulmonary hypertension, severe ventricular dysfunction, severe
atrioventricular (AV) valve regurgitation, known large systemic–The Journal of Thoracic and Carpulmonary artery or venous collateral vessels, or coarctation of the aorta
(defined as>50% narrowing of the aortic isthmus relative to the descend-
ing aorta or 3 m/s peak Doppler flow velocity). In the absence of exclu-
sion criteria and after informed consent, patients were enrolled and
randomized in a 1:1 fashion to either cardiac catheterization or CMR; mo-
dality crossover after randomization was permitted. Data collection began
at the time of enrollment and continued prospectively through preoperative
evaluation, operative and postoperative hospitalization, and clinical assess-
ment 3 months after surgery for the original study.
For the current investigation, continued follow-up of the original cohort
was performed by review of clinical records through most recent clinical
evaluation, loss to follow-up, or death. Data collected included clinical
variables and outcomes between BDG operation and any subsequent
interventions, including preoperative echocardiographic and cardiac cath-
eterization data, operative and postoperative in-hospital clinical data, and
subsequent course through the most recent clinical follow-up visit.Diagnostic Data
Echocardiographic parameters of cardiovascular anatomy and function
deemed relevant in this setting12 were collected from the report of the in-
terpreting staff echocardiographer for the pre-Fontan echocardiogram. In
brief, this included assessment of systemic and pulmonary veins, atrial sep-
tum, AV valve(s) structure and function, ventricular anatomy and function,
outflow tract(s) and semilunar valve function, aortic arch, and mediastinal
branch pulmonary arteries. Secondary review of images was performed in
a blinded fashion to verify anymissing information or to establish degree of
aortic arch obstruction or pulmonary artery stenosis. Pulmonary artery ste-
nosis was graded as moderate or greater with 50% or greater narrowing of
the affected segment relative to the adjacent unobstructed luminal diame-
ter. Distal aortic arch obstruction by echocardiogram was defined as
a Doppler maximum velocity, corrected for proximal velocity, of 1.5 m/s
or more. AV valve regurgitation was categorized as none/trivial, mild, mod-
erate, or severe; although grading definitions were not prespecified by the
trial, typical assessment in our echocardiography laboratory is based on
width of the vena contracta by color Doppler relative to systemic AV valve
annulus diameter, visualized from 2 orthogonal views. Similarly, systemic
ventricular function was graded qualitatively as normal (ejection fraction
50%), mild (ejection fraction 40%-50%), moderate (ejection fraction
30%-40%), and severe dysfunction (ejection fraction<30%).
Patients who had subsequent cardiac catheterizations underwent the
procedure according to clinical practice in our laboratory, which were per-
formed under intravenous sedation or general anesthesia as deemed appro-
priate by the managing team.13 Hemodynamic and angiographic
parameters and type and number of any interventions performed were re-
corded. For patients whose interventions included coil occlusion of sys-
temic–pulmonary collateral (SPC) vessels, all angiograms underwent
secondary review by a single investigator blinded to original randomization
(double-blind) to assess the number of vascular territories addressed by coil
occlusion (eg, excessive SPC circulation arising from the right internal
thoracic artery was categorized as 1 vascular territory).Outcomes
For those who proceeded to Fontan surgery, outcomes from Fontan sur-
gery included the following: (1) intraoperative and postoperative complica-
tions; (2) a composite score of a successful Fontan procedure, comprised of
(a) hospital length of stay of 14 days or less, (b) thoracostomy tube drainage
of 10 days or less, (c) oxygen saturation of 85% or more at the time of hos-
pital discharge, (d) no unplanned postoperative interventions or proce-
dures, and (e) no hospital readmission within 30 days of discharge; and
(3) clinical assessment at most recent follow-up including cutaneous oxy-
gen saturation, clinical well-being, and frequency of new diagnoses or re-
intervention. Clinical well-being included no decline in New York Heart
Association functional class, no decline in ventricular function, anddiovascular Surgery c Volume 146, Number 5 1173
TABLE 1. Patient characteristics
Catheterization
(n ¼ 41)
CMR
(n ¼ 41)
P
value
Age at BDG (mo) 4.8 (2.0-11.9) 5.4 (2.2-10.4) .14
Gender
Male 25 (61) 24 (59) 1.0
Female 16 (39) 17 (41)
Race
White 28 (68) 29 (71) .77
Black 9 (22) 6 (15)
Hispanic 4 (10) 5 (12)
Asian 0 1 (2)
Ventricular anatomy
HLHS 23 (56) 20 (49) .68
Tricuspid atresia 4 (10) 7 (17)
PA/IVS 2 (5) 5 (12)
Double-inlet LV 5 (12) 5 (12)
Single RV 4 (10) 1 (2)
Complex 2-ventricle 2 (5) 2 (5)
Unbalanced AV canal 1 (2) 1 (2)
Underwent Fontan 38 (93%) 38 (93%) 1.0
Pre-Fontan echo data n ¼ 38 n ¼ 38
Body surface area (m2) 0.57 (0.43-0.66) 0.53 (0.43-0.66) .36
Oxygen saturation (%) 85 (65-93) 84 (76-90) .08
Ventricular dysfunction
None 28 (74) 34 (89) .13
Mild 8 (21) 2 (5)
Moderate 2 (5) 2 (5)
Systemic AV valve
regurgitation
None/trivial 15 (39) 29 (76) .002
Mild 22 (58) 9 (24)
Moderate 1 (3) 0 (0)
Suspected aortic arch
obstruction*
9 (24) 5 (13) .38
LPA stenosis
None 13 (34) 16 (42) .61
Mild (25%-50%) 4 (11) 2 (5)
Not visualized 21 (55) 20 (53)
RPA stenosis
None 19 (50) 23 (61) .49
Mild (25%-50%) 0 (0) 0 (0)
Not visualized 19 (50) 15 (39)
Pulmonary venous obstruction
None 34 (89) 32 (84) .74
Mild 0 (0) 1 (3)
Not visualized 4 (11) 5 (13)
Values are median (range) or count (percent). CMR, Cardiac magnetic resonance;
BDG, bidirectional Glenn; HLHS, hypoplastic left heart syndrome; PA/IVS, pulmo-
nary atresia with intact ventricular septum; LV, left ventricle; RV, right ventricle;
AV, atrioventricular; LPA, left pulmonary artery; RPA, right pulmonary artery. *See
Methods section.
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nition of a successful Fontan procedure was developed using a modified
Delphimethod14 by a committee of senior pediatric cardiologists and a con-
genital heart surgeon from our institution not associated with the study.
Statistical Analysis
Analyses were performed on an intention-to-treat basis according to
the original trial randomization. Patient characteristics and outcomes
were compared for those randomized to CMR versus catheterization us-
ing the 2-sample t test or Wilcoxon rank sum test for continuous variables
and Fisher’s exact test for categorical variables. A secondary analysis for
actual treatment received per protocol before BDG was also performed.
The study complies with the Declaration of Helsinki and was approved
by the Boston Children’s Hospital Committee on Clinical Investigation. In-
formed, written consent was obtained from all parents or legal guardians.
We had full access to and take full responsibility for the integrity of the
data. We have all read and agree to the manuscript as written.
RESULTS
Patient Characteristics
Of the 92 patients eligible for inclusion in the original
study, 10 were not enrolled on the basis of exclusion criteria
by screening echocardiogram (aortic coarctation in 7 pa-
tients and pulmonary vein stenosis, restrictive atrial septum,
and suspected pulmonary hypertension in 1 each). All re-
maining 82 patients had informed consent obtained, were
enrolled in the study, and randomized. Three patients in
the original study crossed over to the alternative preopera-
tive evaluation arm and underwent both CMR and catheter-
ization. No patients withdrew from the study; all patients
underwent BDG anastomosis and were subsequently fol-
lowed up through most recent clinical evaluation. No pa-
tients were lost to follow-up. Baseline characteristics were
similar between groups in age, gender, race, ventricular
anatomy, prior operations, body surface area, and oxygen
saturation (Table 1).
Patients Not Referred for Fontan Completion
Of the 82 patients in the original study cohort, 6 (7%)
were not referred for Fontan completion. Two patients
with mild left ventricular hypoplasia were referred for
BDG takedown and 2-ventricle repair, both in the CMR
arm of the original study. In 2 patients BDG was the defin-
itive palliation, both with pulmonary atresia and intact ven-
tricular septum and moderate right ventricular hypoplasia,
with 1 patient in each arm of the original study. There
were 2 (2.4%) deaths that occurred in the period between
BDG and planned Fontan operation, both patients with hy-
poplastic left heart syndrome, progressive tricuspid regurgi-
tation, and right ventricular failure; both were randomized
to the catheterization arm. One patient died at age 10
months of heart failure awaiting heart transplantation and
the other died suddenly out of the hospital at age 14 months.
No patients were lost to follow-up. The remaining 76 under-
went pre-Fontan evaluation including catheterization fol-
lowed by Fontan completion.1174 The Journal of Thoracic and Cardiovascular SurPre-Fontan Imaging Data
For those referred for pre-Fontan evaluation (n ¼ 76),
preoperative echocardiographic findings were similar in
the 2 study groups (Table 1). Most patients had mild
(or less) ventricular dysfunction and mild (or less) AVgery c November 2013
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struction by echocardiogram was common but occurred
with similar frequency in the 2 groups. Mediastinal
branch pulmonary arteries were frequently not able to
be adequately visualized, as has been reported in this set-
ting,11 but when visualized, stenosis was uncommon in
both groups. Pulmonary vein stenosis was present in 1
patient.
Pre-Fontan Catheterizations
All patients who proceeded to Fontan operation under-
went preoperative cardiac catheterization (n ¼ 76,
Table 2). Four patients had more than 1 catheterization
between BDG and Fontan operations: 2 with recurrent co-
arctation had repeat catheterizations for balloon dilation,
1 with elevated filling pressures and excessive SPC ves-
sels had a repeat hemodynamic catheterization, and 1
with stenosis of the left upper pulmonary vein underwent
repeat catheterization for balloon dilation. Patients in the
CMR arm of the study underwent catheterization at
a younger age and sooner after BDG than those in the
catheterization arm. Patients in the CMR arm had slightly
higher measured cardiac index, but all otherTABLE 2. Pre-Fontan catheterization
Catheterization
(n ¼ 38)
CMR
(n ¼ 38) P value
Age at pre-Fontan
catheterization* (y)
2.7 (1.8-4.3) 2.3 (1.5-3.8) .003
Time from BDG to pre-Fontan
catheterization (y)
2.2 (1.3-4.0) 1.7 (1.0-3.2) .001
Less than 1 pre-Fontan
catheterizationy
1 (3) 3 (8) .62
Fluoroscopy time (min) 51 (20-93) 45 (22-112) .25
Aortic saturation (%) 86 (72-91) 85 (73-96) .17
Cardiac index (L $ min1 $ m2) 3.4 (2.1-9.4) 3.9 (2.1-5.7) .04
Common atrial mean pressure
(mm Hg)
8 (4-16) 9 (3-14) .79
Ventricular end-diastolic pressure
(mm Hg)
8 (4-16) 8 (3-14) .85
Pulmonary artery mean pressure
(mm Hg)
12 (8-22) 13 (8-23) .75
Qp:Qs ratio 0.7 (0.4-1.8) 0.6 (0.4-1.0) .06
Pulmonary vascular resistance
(Wood units/m2)
1.5 (0.5-3.8) 1.5 (0.9-3.1) .67
Distal aortic arch obstruction
(10 mm Hg)
3 (8) 2 (5) .79
Moderate LPA stenosisz 2 (5) 1 (3) .79
Moderate RPA stenosis 1 (3) 1 (3) 1.0
Values are median (range) or count (percent). CMR, Cardiac magnetic resonance;
BDG, bidirectional Glenn; Qp:Qs, pulmonary flow/systemic flow; LPA, left pulmo-
nary artery; RPA, right pulmonary artery. *For the 4 patients with more than 1 cathe-
terization in the interval between BDG and Fontan operations, hemodynamic data
from the study intended to be the pre-Fontan study are presented. yRepeat balloon di-
lation of recurrent coarctation in 2 patients, repeat dilation of isolated pulmonary vein
stenosis in 1 patient, and repeat assessment of elevated filling pressures in 1 patient.
zModerate stenosis defined as 50% or greater narrowing relative to the adjacent
unobstructed lumen diameter; see Methods section for details.
The Journal of Thoracic and Carhemodynamic parameters obtained at catheterization
were similar between groups, including common atrial
and ventricular end-diastolic pressures, mean pulmonary
artery pressure, pulmonary/systemic flow ratio, and calcu-
lated pulmonary vascular resistance. The frequencies of
distal arch obstruction and pulmonary artery stenosis
were similar between groups.
Transcatheter Interventions
Interventions performed at pre-Fontan catheterization
were common, occurring in approximately 70% of the
whole cohort, with no difference between patients in the 2
study arms (Table 3). The most common intervention per-
formed was coil occlusion of excessive SPC vessels
(Figure 1), which occurred in about two thirds of patients
and did not differ between groups. When SPC interventions
were analyzed by the number of vascular territories ad-
dressed by coil occlusion, the median number of vascular
territories (2) was also similar between groups, as were the
number of patients in each group with 3 to 4 vascular terri-
tories addressed. Other less commonly performed interven-
tions, such as balloon dilation of branch pulmonary arteries
or recurrent coarctation, did not differ between groups.
Surgical Fontan Data
Similar to age at catheterization, patients in the CMR arm
were slightly younger at the time of the Fontan operation
(Table 4). The majority of patients underwent lateral tunnel
fenestrated Fontan with no difference in Fontan type be-
tween groups. Patients in the catheterization arm underwent
more additional intraoperative procedures. There was 1 in-
traoperative complication in each group: a patient with Fon-
tan pathway obstruction required baffle revision andTABLE 3. Pre-Fontan catheterization interventions
Catheterization
(n ¼ 38)
CMR
(n ¼ 38)
P
value
Patients with any catheterization
intervention
30 (79) 27 (71) .60
Interventions type 30 27 .44
Coil occlusion SPC 23 25 .81
Coil occlusion VV collateral 5 3 .71
Pulmonary artery balloon dilation 6 4 .74
Coarctation balloon dilation 5 1 .20
If coil occlusion of SPCs, median
No. of vascular territories
addressed*
2 (1-4) 2 (1-3) .15
1 vascular territory 8 12 .29
2 vascular territories 10 12
3 vascular territories 4 1
4 vascular territories 1 0
Values are median (range) or count (percent). CMR, Cardiac magnetic resonance;
SPC, systemic–pulmonary collateral; VV, venovenous. *For excessive SPC collateral
flow, vascular territories were defined by feeding blood vessel arterial supply; see
Methods section for details.
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TABLE 4. Fontan surgical data by treatment assignment
Catheterization
(n ¼ 38)
CMR
(n ¼ 38) P value
Operative data
Age at Fontan operation (y) 2.7 (1.9-4.3) 2.4 (1.6-3.8) .02
Fontan type .74
Lateral tunnel fenestrated 34 (89) 32 (84)
Extracardiac conduit
fenestrated
4 (11) 6 (16)
Other surgical procedures 26 (68) 15 (39) .02
Pulmonary arterioplasty 11 8
Atrioventricular valve
plasty
4 2
Cardiopulmonary bypass
time (min)
106 (64-180) 101 (63-192) .64
Aortic crossclamp time (min) 49 (0-104) 48 (0-91) .97
Any intraoperative
complication*
1 (3) 1 (3) 1.0
Fontan pathway pressure
(mm Hg)y
14 (10-18) 14 (8-17) .20
Common atrial pressure
(mm Hg)y
7 (4-13) 7 (4-10) .25
Postoperative course
In-hospital mortality 0 0 1.0
Length of mechanical
ventilation (d)
2 (1-27) 2 (1-25) .37
Thoracostomy tube time (d) 7 (3-30) 7 (4-31) .88
CICU length of stay (d) 4 (2-37) 4 (2-41) .74
Hospital length of stay (d) 11 (6-52) 10 (6-72) .83
Oxygen saturation at
discharge (%)
86 (80-98) 86 (75-100) .79
Any major postoperative
complicationz
2 (5) 0 (0) .49
Any minor postoperative
complication
24 (63) 23 (61) 1.0
Arrhythmia requiring
treatmentx
18 (47) 19 (50) 1.0
Reintubation 3 (8) 2 (5) 1.0
Pneumonia or urinary
tract infection
1 (3) 2 (5) 1.0
Line infection 1 (3) 1 (3) 1.0
Unplanned procedure 30
days after Fontan
12 (32) 5 (13) .10
Hospital readmission 30
days of discharge
3 (8) 1 (3) .62
Values are median (range) or count (percent). CMR, Cardiac magnetic resonance;
CICU, cardiac intensive care unit. *Excludes transient arrhythmias. Fontan baffle re-
vision required in 1 patient, hypotension requiring 1 minute of cardiopulmonary re-
suscitation in 1 patient. yMean postoperative value in mm Hg over first 24 hours.
zIncludes mediastinitis requiring debridement, and postoperative seizure. xMost
commonly transient junctional rhythm requiring temporary pacing.
FIGURE 1. Systemic–pulmonary collateral vessels. Catheter angiogram
in a patient undergoing pre-Fontan evaluation shows an injection into the
proximal right internal thoracic artery in an anteroposterior projection.
The right internal thoracic artery is dilated with multiple systemic–pulmo-
nary artery connections to the right lung vasculature. For the purposes of
comparison of the extent of such collaterals among patients who underwent
coil occlusion, this would be categorized as 1 vascular territory.
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cardiopulmonary resuscitation for approximately 1 minute.
Total cardiopulmonary bypass times, postoperative Fontan
baffle pressure, and mean atrial pressure did not differ be-
tween groups.
Postoperative Fontan Outcomes
There were no postoperative deaths (Table 4). Major
complications occurred in 2 patients, both in the catheteri-
zation group; 1 patient with mediastinitis required
surgical debridement, and 1 patient had a postoperative
seizure. Minor postoperative complications occurred with
similar frequency in both groups; the majority of these
were transient junctional rhythm requiring temporary exter-
nal pacing. There were no significant differences between
groups in duration of mechanical ventilation, thoracostomy
tube drainage, length of stay in the intensive care unit,
length of hospital stay, and oxygen saturation at discharge.
The number of unplanned postoperative procedures did
not significantly differ between groups, the majority of
which were postoperative interventional catheterizations
(10 patients) and placement of additional thoracostomy
tubes (5 patients). Hospital readmission rates within 30
days of discharge were similar between groups.
Patients in both groups met the 5-element definition of
a clinically successful Fontan operation with similar1176 The Journal of Thoracic and Cardiovascular Surfrequencies (55% in the catheterization group vs 71% in
the CMR group; P ¼ .23) (Table 5 and Figure 2).Late Follow-up
All patients who underwent the Fontan operation were
alive and clinically well at a median age of 8.8 yearsgery c November 2013
TABLE 5. Outcome of Fontan operation
Catheterization
(n ¼ 38)
CMR
(n ¼ 38) P value
Clinically successful Fontan
operation*
Hospital LOS 14 d 30 (79) 31 (82) 1.0
Thoracostomy tube drains
10 d
33 (87) 31 (82) .75
Discharge oxygen saturation
85%
24 (63) 26 (68) .81
No unplanned postoperative
procedure
26 (68) 33 (87) .10
No readmission within
30 d of discharge
35 (92) 37 (97) .62
Meets all 5 criteria 21 (55) 27 (71) .23
CMR, Cardiac magnetic resonance; LOS, length of stay. *Component measures
defined by consensus panel; see Methods section for details.
TABLE 6. Late follow-up after Fontan operation
Catheterization
(n ¼ 38)
CMR
(n ¼ 38) P value
Age at most recent
follow-up (y)
8.8 (6.9-10.2) 8.8 (6.9-10.1) .95
Patient alive 38 (100) 38 (100) 1.0
Cutaneous oxygen
saturation (%)
94 (80-99) 95 (82-100) .31
Any procedure after
Fontan*
18 (47) 15 (39) .64
Clinically welly 38 (100) 38 (100) 1.0
CMR, Cardiac magnetic resonance. *Most common interventions included device
closure Fontan fenestration in 25, pulmonary artery dilation in 4, and pacemaker
implantation in 3. yDefined as no decline in New York Heart Association class
and no decline in ventricular function or worsening atrioventricular valve regurgi-
tation.
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groups at 95%. Less than half of the patients in both groups
underwent subsequent procedures, the majority of which
were catheterizations for device closure of baffle fenestra-
tions (n ¼ 25). No patients had worsening New York Heart
Association functional class, deterioration in ventricular
function, or worsening AV valve regurgitation at most re-
cent follow-up.
These results represent an intention-to-treat analysis
from the original randomized treatment assignment before
BDG. When analyzed per protocol for actual treatment
received before BDG, the results are similar with no sta-
tistically significant changes in the outcomes reported
above.FIGURE 2. Post-Fontan outcomes. Component definitions of a successful
outcome from Fontan surgery developed by consensus panel are demon-
strated by the study’s original treatment assignment before bidirectional
Glenn operation—cardiac magnetic resonance (CMR) or catheterization.
Components included hospital length of stay (LOS) of 14 days or less, chest
tube drains in for 10 days or less, discharge oxygen saturation of 85% or
more, no unplanned post-Fontan procedures, and no hospital readmission
in 30 days or less of discharge.
The Journal of Thoracic and CarDISCUSSION
The long-term follow-up of this cohort from a random-
ized clinical trial showed that patients managed with a non-
invasive imaging strategy using echocardiography and
CMR before BDG, versus routine cardiac catheterization,
had no detectable differences in clinical outcomes after
Fontan operation at a median age of 8.8 years. Furthermore,
the clinical course before and after Fontan operation, hemo-
dynamic profile at pre-Fontan catheterization, postoperative
course, and post-Fontan outcomes were indistinguishable
between the groups.
It is worth noting that the only statistically significant dif-
ferences between groups were age at pre-Fontan evaluation
and age at Fontan, which was younger at both in the CMR
group. The reason for this finding is not entirely clear, as in
all other respects the 2 groups were similar, including clin-
ical profile, hemodynamic findings at catheterization, and
types and frequencies of catheter intervention. Moreover,
the vast majority of patients in both groups were clinically
well and referred for elective evaluation for candidacy for
Fontan. It is conceivable that the CMR group was referred
at a younger age because many of these patients had never
undergone catheterization, which may have influenced pro-
vider practice and resulted in earlier referrals for pre-Fontan
catheterization and surgery. Nevertheless, aside from
slightly younger age at Fontan, the groups had no apprecia-
ble differences in outcomes at a comparable age at latest fol-
low-up.
One of the main purposes of this study was to determine
whether there was any evidence of a delayed therapeutic
effect from transcatheter pre-BDG interventions, primarily
coil occlusion of SPCs. Given that the frequency of coil
occlusion of SPCs before BDG was much lower in the
CMR group as compared with the catheterization group,
it is possible that the beneficial effects of this intervention,
if any, may manifest during follow-up. However, we did
not find any evidence for such an effect; indeed, the fre-
quency of intervention for coil occlusion at pre-Fontandiovascular Surgery c Volume 146, Number 5 1177
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ted to further quantify the overall burden of SPC flow at
pre-Fontan catheterization by assessing the number of vas-
cular territories addressed by coil occlusion, which did not
differ between groups. Although this is only semiquantita-
tive, it demonstrates that patients in the CMR group did
not have disproportionately more extensive SPCs than pa-
tients in the catheterization arm. Considering that 20% of
patients in the catheterization arm of the study had already
undergone coil occlusion of SPCs before BDG, the results
suggest that coil occlusion of such vessels may only pro-
vide a temporary reduction in SPC flow, and as this had no
impact on course during and after BDG, the utility of rou-
tine occlusion of such vessels may need to be reevaluated.
The recent development of a new CMR technique to quan-
tify SPC flow15,16 provides an opportunity not only to
study the hemodynamic burden and natural history of
SPCs in patients with functional single ventricle, but
also to facilitate prospective investigations designed to
determine the indications and efficacy of coil occlusion
of SPCs.
Limitations
This was a single-center trial carried out in a high-volume
referral institution with expertise in CMR, and the results
may not be generalizable to other practice settings; confir-
mation of the results from a multicenter study would be de-
sirable. The study cohort was a selected group of patients
based on screening echocardiogram, and these results
should not be extrapolated to higher risk candidates for
BDG. In addition, the study was powered to measure a mod-
est difference in the incidence of adverse events for the pre-
BDG evaluation, not to demonstrate the equivalency of
long-term impact and outcomes after transcatheter inter-
ventions; it is conceivable that with a larger sample size
and longer follow-up period, some differences in long-
term outcomes of such interventions would be more
apparent.
CONCLUSIONS
Compared with routine pre-BDG cardiac catheterization,
patients evaluated with a noninvasive strategy alone had
equivalent clinical and hemodynamic profiles before
Fontan, similar post-Fontan outcomes, and similar1178 The Journal of Thoracic and Cardiovascular Surclinical status at a median follow-up of 6 years after Fontan.
For selected patients, a pre-BDG evaluation with
echocardiography and CMR is an acceptable alternative
to catheterization.References
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